Cummins, K. D., Jane, S. M., Ninkovic, S., Bazargan, A., Filshie, R., Sutrave, G., . . . Wei, A. (2014). Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia. Nature Publishing Group.
Stile di citazione ChicagoCummins, K D., et al. Sorafenib Priming May Augment Salvage Chemotherapy in Relapsed and Refractory FLT3-ITD-positive Acute Myeloid Leukemia. Nature Publishing Group, 2014.
Citazione MLACummins, K D., et al. Sorafenib Priming May Augment Salvage Chemotherapy in Relapsed and Refractory FLT3-ITD-positive Acute Myeloid Leukemia. Nature Publishing Group, 2014.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.